TWO OF THE THREE BLOOD BROTHERS reported continued improvement in their financial condition as second quarter earnings reports were made public.
This news, however, was overshadowed by speculation about the failure of Quest Diagnostics Incorporated to consummate its purchase of SmithKline Beecham Clinical Laboratories (SBCL) during the month of July.
Quest Diagnostics and Laboratory Corporation of America
Subscriber-Only Content. Please Log In.
You are trying to access subscribers-only content. If you are a subscriber, please log in.
If you are not a subscriber, click here to see subscription offers.
Subscribers will have instant access to the Dark Report library, 1997-the present, giving you the most convenient, accessible archive available in laboratory business intelligence today!
To read our FREE article previews, go to The Dark Report Insider.